Decrease of plasma N-terminal pro β-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure

Chinese Medical Journal

Volumn 122, Issue 6, 2009, Pages 617-621

  Ding, Li Gang ^a   Hua, Wei ^a   Zhang, Shu ^a   Chu, Jian Min ^a   Chen, Ke Ping ^a   Wang, Yang ^a   Wang, Fang Zheng ^a   Chen, Xin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiac resynchronization therapy; Chronic heart failure; N terminal pro type natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; MALE; PATIENT MONITORING; PREDICTOR VARIABLE; QRS COMPLEX; RECEIVER OPERATING CHARACTERISTIC; TREATMENT RESPONSE; AGED; BLOOD; HEART PACING; METHODOLOGY; MIDDLE AGED; PROGNOSIS; TIME;

AGED; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; TIME FACTORS;

EID: 67649786631     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.06.005     Document Type: Article

References (22)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
3. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug resistant congestive heart failure. Am J Cardiol 2002; 89: 346-350.
4. Yu CM, Abraham WT, Bax J, Chung E, Fedewa M, Ghio S, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT) - study design. Am Heart J 2005; 149: 600-605. 5. Penicka M, Bartunek J, De BB, Vanderheyden M, Goethals M, De ZM, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 2004; 109: 978-983.
5. Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, de PC, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005; 26: 1094-1100.
6. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006; 113: 969-976.
7. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616.
8. Zhang XY, Zhu JH. Clinical significance of N-terminal pro brain natriuretic peptide. Chin Med J 2004; 117: 1716-1722.
9. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
10. Bettencourt P, Frioes F, Azevedo A, Dias P, Pimenta J, Rocha Goncalves F, et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 2004; 93: 45-48.
11. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001; 37: 386-391.
12. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-1230.
13. Lellouche N, De DC, Cesario DA, Vaseghi M, Horowitz BN, Mahajan A, et al. Usefulness of preimplantation B type natriuretic peptide level for predicting response to cardiac resynchronization therapy. Am J Cardiol 2007; 99: 242-246.
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
15. Miyatake K, Izumi S, Okamoto M, Kinoshita N, Asonuma H, Nakagawa H, et al. Semiquantitative grading of severity of mitral regurgitation by real time two dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986; 7: 82-88.
16. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal pro brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004; 110: 2168-2174.
17. Bettencourt P, Frioes F, Azevedo A, Dias P, Pimenta J, Rocha Goncalves F, et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 2004; 93: 45-48.
18. Stanek B, Frey B, Hulsmann M, Berger R, Sturm B, Strametz Juranek J, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 436-442.
19. Pitzalis MV, Iacoviello M, Di SF, Romito R, Guida P, De TE, et al. Prognostic value of brain natriuretic peptide iN-the management of patients receiving cardiac resynchronization therapy. Eur J Heart Fail 2006; 8: 509-514.
20. Kubanek M, Malek I, Bytesnik J, Fridl P, Riedlbauchova L, Karasova L, et al. Decrease in plasma B type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months. Eur J Heart Fail 2006; 8: 832-840.
21. Tanabe M, Dohi K, Onishi K, Nakata T, Sato Y, Nakajima H, et al. Biventricular pacing worsened dyssynchrony in heart failure patient with right bundle branch block. Int J Cardiol 2008; Epub ahead of print.
22. Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation 2004; 109: 300-307.